The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key ...
TUCKER, Ga. (AP) — TUCKER, Ga. (AP) — GMS Inc. (GMS) on Thursday reported a loss of $21.4 million in its fiscal third quarter. The Tucker, Georgia-based company said it had a loss of 55 cents per ...
Equities research analysts at Zacks Research reduced their FY2025 earnings per share (EPS) estimates for shares of Burlington ...
Equities research analysts at Zacks Research reduced their Q3 2025 earnings per share estimates for shares of AptarGroup in a ...
On a per-share basis, the Calgary Alberta Canada, Alberta-based company said it had net income of 39 cents. Earnings, adjusted for non-recurring costs, were 66 cents per share. The results missed Wall ...
2hOpinion
Zacks Investment Research on MSNNew Strong Buy Stocks for March 6thList today: Molson Coors Beverage Company TAP: This beer and malt beverages company has seen the Zacks Consensus Estimate for ...
2h
Zacks Investment Research on MSNNew Strong Sell Stocks for March 6thList today: Artelo Biosciences, Inc. ARTL is a clinical stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 50.5% downward over the last 60 ...
SAN DIEGO (AP) — SAN DIEGO (AP) — Fate Therapeutics Inc. (FATE) on Wednesday reported a loss of $52.2 million in its fourth quarter. On a per-share basis, the San Diego-based company said it had a ...
The stock market stood its ground on Wednesday, with all major indices eking out gains as President Donald Trump softened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results